MM-GBSA binding free energy decomposition and T cell receptor engineering

Journal of Molecular Recognition

Volumn 23, Issue 2, 2010, Pages 142-152

  Zoete, V ^a   Irving, M B ^b   Michielin, O ^a,b,c,d  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^c Multidisciplinary Oncology Center   (Switzerland)

^d The National Centre of Competence in Research (NCCR)   (Switzerland)

Author keywords

Free energy simulations; Protein engineering; T cell receptor

Indexed keywords

EID: 76649121529     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1005     Document Type: Article

References (71)

1. Amidon GL, Yalkowsky SH, Anik ST, Valvani SC. 1975. Solubility of nonelectrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach. J. Phys. Chem. 79: 2239-2246.
2. Balius TE, Rizzo RC. 2009. Quantitative prediction of fold resistance for inhibitors of EGFR. Biochemistry 48: 8435-8448.
3. Bash PA, Singh UC, Brown FK, Langridge R, Kollman PA. 1987. Calculation of the relative change in binding free energy of a protein-inhibitor complex. Science 235: 574-576.
4. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The protein data bank. Nucleic Acids Res. 28: 235-242.
5. Bonnet P, Bryce RA. 2005. Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: application to influenza neuraminidase. J. Mol. Graph Model 24: 147-156.
6. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. 1983. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4: 187-217.
7. Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. 2005. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J. Exp. Med. 201: 1243-1255.
8. Chipot C, Pohorille A. 2007. Free Energy Calculations: Theory and Applications in Chemistry and Biology. Springer: Berlin.
9. Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. 2005. Highaffinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J. Mol. Biol. 346: 223-239.
10. Dietrich PY, Le Gal FA, Dutoit V, Pittet MJ, Trautman L, Zippelius A, Cognet I, Widmer V, Walker PR, Michielin O, Guillaume P, Connerotte T, Jotereau F, Coulie PG, Romero P, Cerottini JC, Bonneville M, Valmori D. 2003. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J. Immunol. 170: 5103-5109.
11. Doytchinova IA, Flower DR. 2006. Modeling the peptide-T cell receptor interaction by the comparative molecular similarity indices analysissoft independent modeling of class analogy technique. J. Med. Chem. 49: 2193-2199.
12. Dunbrack RL, Jr. 2002. Rotamer libraries in the 21st century. Curr. Opin. Struct. Biol. 12: 431-440.
13. Dunn SM, Rizkallah PJ, Baston E, Mahon T, Cameron B, Moysey R, Gao F, Sami M, Boulter J, Li Y, Jakobsen BK. 2006. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci. 15: 710-721.
14. Espinoza-Fonseca LM, Kast D, Thomas DD. 2008. Thermodynamic and structural basis of phosphorylation-induced disorder-to-order transition in the regulatory light chain of smooth muscle myosin. J. Am. Chem. Soc. 130: 12208-12209.
15. Flower DR, McSparron H, Blythe MJ, Zygouri C, Taylor D, Guan P, Wan S, Coveney PV, Walshe V, Borrow P, Doytchinova IA. 2003. Computational vaccinology: quantitative approaches. Novartis Found Symp. 254: 102-120 (discussion 120-5, 216-22, 250-2).
16. Fogolari F, Tosatto SC. 2005. Application of MM/PBSAcolony free energy to loop decoy discrimination: toward correlation between energy and root mean square deviation. Protein Sci. 14: 889-901.
17. Foloppe N, Hubbard R. 2006. Towards predictive ligand design with freeenergy based computational methods? Curr. Med. Chem. 13: 3583-3608.
18. Gilson MK, Zhou HX. 2007. Calculation of protein-ligand binding affinities. Ann. Rev. Biophys. Biomol. Struct. 36: 21-42.
19. Gilson MK, Honig B. 1988a. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins 4: 7-18.
20. Gilson MK, Honig BH. 1988b. Energetics of charge-charge interactions in proteins. Proteins 3: 32-52.
21. Gohlke H, Kiel C, Case DA. 2003. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J. Mol. Biol. 330: 891-913.
22. Gohlke H, Kuhn LA, Case DA. 2004. Change in protein flexibility upon complex formation: analysis of Ras-Raf using molecular dynamics and a molecular framework approach. Proteins 56: 322-337.
23. Gouda H, Kuntz ID, Case DA, Kollman PA. 2003. Free energy calculations for theophylline binding to an RNA aptamer: MM-PBSA and comparison of thermodynamic integration methods. Biopolymers 68: 16-34.
24. Haidar JN, Pierce B, Yu Y, Tong W, Li M, Weng Z. 2009. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins 74: 948-960.
25. Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/ MHC. Proc. Natl Acad. Sci. USA 97: 5387-5392.
26. Hou T, Yu R. 2007. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. J. Med. Chem. 50: 1177-1188.
27. Hudrisier D, Kessler B, Valitutti S, Horvath C, Cerottini JC, Luescher IF. 1998. The efficiency of antigen recognition by CD8{thorn}CTL clones is determined by the frequency of serial TCR engagement. J. Immunol. 161: 553-562.
28. Huo S, Massova I, Kollman PA. 2002. Computational alanine scanning of the 1: 1 human growth hormone-receptor complex. J. Comp. Chem. 23: 15-27.
29. Irving MB, Zoete V, Andre M, Schmid D, Ferber M, Reichenbach P, Guillaume P, Hacker D, Luescher, Speiser D, Romero P, Rufer N, Michielin O. Rational TCR design. step-by-step, Structure-Based Optimization of an Anti-cancer TCR. Submitted.
30. Karanicolas J, Kuhlman B. 2009. Computational design of affinity and specificity at protein-protein interfaces. Curr. Opin. Struct. Biol. 19: 458-463.
31. Kirkwood JG. 1935. Statistical mechanics of fluid mixture. J. Chem. Phys. 3: 300-313.
32. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TEr. 2000. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 33: 889-897.
33. Kuhn B, Kollman PA. 2000. A ligand that is predicted to bind better to avidin than biotin: insights from computational fluorine scanning. J. Am. Chem. Soc. 122: 3909-3916.
34. Ladbury JE. 1996. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem. Biol. 3: 973-980.
35. Lafont V, Schaefer M, Stote RH, Altschuh D, Dejaegere A. 2007. Proteinprotein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies ''efficient amino acids.'' Proteins 67: 418-434.
36. Lee MS, Feig M, Salsbury FR, Jr Brooks CL, III. 2003. New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations. J. Comput. Chem. 24: 1348-1356.
37. Lee MS, Salsbury FR, Jr Brooks CL, III. 2002. Novel generalized Born methods. J. Chem. Phys. 116: 10606-10614.
38. Li Y, Moysey R, Molloy PE, Vuidepot AL, Mahon T, Baston E, Dunn S, Liddy N, Jacob J, Jakobsen BK, Boulter JM. 2005. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 23: 349-354.
39. Lyons DS, Lieberman SA, Hampl J, Boniface JJ, Chien Y, Berg LJ, Davis MM. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5: 53-61.
40. Massova I, Kollman PA. 1999. Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J. Am. Chem. Soc. 121: 8133-8143.
41. Meirovitch H. 2007. Recent developments in methodologies for calculating the entropy and free energy of biological systems by computer simulation. Curr. Opin. Struct. Biol. 17: 181-186.
42. Michalik L, Zoete V, Krey G, Grosdidier A, Gelman L, Chodanowski P, Feige JN, Desvergne B, Wahli W, Michielin O. 2007. Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior. J. Biol. Chem. 282: 9666-9677.
43. Michielin O, Karplus M. 2002. Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. J. Mol. Biol. 324: 547.
44. Moreira IS, Fernandes PA, Ramos MJ. 2007. Computational alanine scanning mutagenesis-an improved methodological approach. J. Comp. Chem. 28: 644-654.
45. Moreira IS, Fernandes PA, Ramos MJ. 2006. Unraveling the importance of protein-protein interaction: application of a computational alanine-scanning mutagenesis to the study of the IgG1 streptococcal protein G (C2 fragment) complex. J. Phys. Chem. B 110: 10962-10969.
46. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
47. Pearlman DA. 2005. Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase. J. Med. Chem. 48: 7796-7807.
48. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612.
49. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. 1996. Kinetic discrimination in T-cell activation. Proc. Natl Acad. Sci. USA 93: 1401-1405.
50. Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA. 2008. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J. Immunol. 180: 6116-6131.
51. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. 2008. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8: 299-308.
52. Rosette C, Werlen G, Daniels MA, Holman PO, Alam SM, Travers PJ, Gascoigne NR, Palmer E, Jameson SC. 2001. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15: 59-70.
53. Rudolph MG, Stanfield RL, Wilson IA. 2006. How TCRs bind MHCs, peptides, and coreceptors. Ann. Rev. Immunol. 24: 419-466.
54. Schmid DA, Posevitz V, Irving MB, Zoete V, Hebeisen M, Posevitz-Fejfar A, Sarria FJC, Reichenbach P, Gomez-Eerland R, Thome M, Schumacher TNM, Speiser DE, Romero P, Michielin O, Rufer N. 2009. Evidence for an avidity threshold limiting/constraining the function of T cells expressing engineered TCRs of high affinities. In preparation.
55. Smith GD, Blessing RH, Ealick SE, Fontecilla-Camps JC, Hauptman HA, Housset D, Langs DA, Miller R. 1997. Ab initio structure determination and refinement of a scorpion protein toxin. Acta Crystallogr. D Biol. Crystallogr. 53: 551-557.
56. Srinivasan J, Miller J, Kollman PA, Case DA. 1998. Continuum solvent studies of the stability of RNA hairpin loops and helices. J. Biomol. Struct. Dyn. 16: 671-682.
57. Still WC, Tempczyk A, Hawley RC, Hendrickson T. 1990. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112: 6127-6129.
58. Strelkov SV, Schumacher J, Burkhard P, Aebi U, Herrmann H. 2004. Crystal structure of the human lamin A coil 2B dimer: implications for the head-to-tail association of nuclear lamins. J. Mol. Biol. 343: 1067-1080.
59. Swanson JM, Henchman RH, McCammon JA. 2004. Revisiting free energy calculations: a theoretical connection to MM/PBSA and direct calculation of the association free energy. Biophys. J. 86: 67-74.
60. Tembe BL, Mc Cammon JA. 1984. Ligand-receptor interactions. Comput. Chem. 8: 281-283.
61. Tidor B, Karplus M. 1994. The contribution of vibrational entropy to molecular association. J. Mol. Biol. 238: 405-414.
62. Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, Rubio-Godoy V, Walker PR, Rimoldi D, Lienard D, Cerottini JC, Romero P, Dietrich PY. 2002. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J. Immunol. 168: 4231-4240.
63. Wan S, Coveney PV, Flower DR. 2005. Molecular basis of peptide recognition by the TCR: affinity differences calculated using large scale computing. J. Immunol. 175: 1715-1723.
64. Yip YL, Zoete V, Scheib H, Michielin O. 2006. Structural assessment of single amino acid mutations: application to TP53 function. Hum. Mutat. 27: 926-937.
65. Zhang N, Jiang Y, Zou J, Zhuang S, Jin H, Yu Q. 2007. Insights into unbinding mechanisms upon two mutations investigated by molecular dynamics study of GSK3beta-axin complex: role of packing hydrophobic residues. Proteins 67: 941-949.
66. Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LY, Li Y, Molloy PE, Dunn SM, Jakobsen BK, Rosenberg SA, Morgan RA. 2007. High-affinity TCRs generated by phage display provide CD4 {thorn}T cells with the ability to recognize and kill tumor cell lines. J. Immunol. 179: 5845-5854.
67. Zoete V, Irving MB, Ferber M, André M, Schmid D, Ruffer N, Michielin O. Rational TCR design. In silico approach no design sequence modifications. Submitted.
68. Zoete V, Meuwly M. 2006. Importance of individual side chains for the stability of a protein fold: computational alanine scanning of the insulin monomer. J. Comput. Chem. 27: 1843-1857.
69. Zoete V, Meuwly M, Karplus M. 2005. Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Proteins 61: 79-93.
70. Zoete V, Michielin O. 2007. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex. Proteins 67: 1026-1047.
71. Zwanzig RW. 1954. High-temperature equation of state by a perturbation method I. Nonpolar gases. J. Chem. Phys. 22: 1420-1426.